Professor Dr. See Mee-Hoong Professor Dr. See Mee-Hoong is an esteemed senior lecturer at the University of Malaya and a dedicated Consultant Oncoplastic Breast Surgeon at the University Malaya Medical Center (UMMC). Graduating with her undergraduate medical degree from UPM in 2003, she continued her academic excellence by earning her Master's Degree in Surgery (General Surgery) from the University of Malaya in May 2011 and obtained her fellowship in Breast Oncoplastic training from 2012 to 2015 in Universiti Malaya and Mahidol University, Thailand. Currently, she is nationally registered as a Breast Oncoplastic Surgeon. Her commitment to medical education and clinical practice led her to join the University Malaya Medical Faculty in 2012, where she specialized as a clinical lecturer focusing on Breast Oncoplastic Surgery. Dr. See further honed her skills as an honorary fellow at Siriraj Hospital, Mahidol University, Bangkok, Thailand in 2013, and later completed advanced training in minimally invasive techniques and Cryoablation at Kameda Medical Centre under Dr. Eisuke Fukuma in 2016. In 2022, Dr. See underwent robotic breast surgery training at Chang Hua Christian Medical Centre, Taichung, Taiwan. She has since pioneered minimally invasive breast surgeries at UMMC, offering patients the benefits of early recovery, smaller scars, better aesthetic outcomes, and comparable oncological results. A pioneer in Malaysia, she introduced 2D and 3D endoscopic nipple-sparing mastectomy (NSM) as early as 2019 and pioneer the FIRST MALAYSIA Robotic NSM with immediate implant reconstruction in 2025 . She has also been elected as a council member of Breast Surgical International in 2024, marking significant milestones in her leadership and expertise. Dr. See serves as the clinical head of the Breast Surgery Unit at UMMC (currently known as the Breast and Endocrine Unit), where she leads a team committed to providing high-quality care to patients. Her research interests span Clinical Breast Surgical Oncology, including Oncoplastic Surgery, Minimally Invasive and Robotic Breast Surgery, Enhanced Recovery After Surgery (ERAS), and Intraoperative Radiotherapy (IORT). She has published over 70 scientific papers, led the development of Decision Aids in Breast Reconstruction, and is actively involved in multiple clinical trials, including the TARGIT-B trial. Dr. See is also actively engaged in advancing artificial intelligence (AI) in breast cancer diagnosis. She is currently collaborating with Kyungpook National University, Daegu, South Korea, on a clinical trial exploring AI applications for breast cancer diagnostics and treatment planning. A driving force in Dr. See's work is her passion for uniting Southeast Asian and Asian breast surgeons through knowledge sharing and collaboration. She spearheads this effort through the Asian Breast Surgery Forum (ABSF – an ECHO Project), which she leads in collaboration with the University of New Mexico’s Project ECHO®. The forum connects 12 Asian countries, fostering the exchange of expertise and best practices in breast surgery. Dr. See is actively involved in various international surgical organizations, including the International Oncoplastic Breast Surgery (IOPBS) and the International Endoscopic and Robotic Breast Surgery (IERBS) societies, contributing to the global advancement of breast surgical practices. Currently, Dr. See serves as the Deputy Head of the Visibility Unit in the Faculty of Medicine at the University of Malaya. Her leadership and vision continue to impact the field of breast surgery, both regionally and globally, as she remains dedicated to enhancing surgical standards, research, and patient outcomes.

Professor Dr. Yvonne Lim Ai Lian is the Associate Deputy Vice-Chancellor (Academic and International) at Universiti Malaya and a Senior Professor in the Department of Parasitology, Faculty of Medicine. She is also a member of the University Senate. A Fellow and former Council Member of the Academy of Sciences Malaysia (ASM). She was the co-chair of the APRU Asia Pacific Women in Leadership (APWiL) Programme and currently serves on the International Advisory Committee of the Association of Pacific Rim Universities. Throughout her distinguished career, she has held several key leadership roles at both university and national levels, including Deputy Dean (Research) at the Faculty of Medicine, Director of the International Relations Office, and Associate Vice-Chancellor of Global Engagement at Universiti Malaya. She has also served as President of the Malaysian Society of Parasitology and Tropical Medicine and as a Council Member of the Academy of Sciences Malaysia. Her research focuses on deciphering the intricate host-parasite-environment interactions that contribute to disease in indigenous and underserved communities, aiming to develop multi-targeted solutions. Additionally, she investigates the diversity of gut and skin microbiomes across populations spanning various socioeconomic and ecological landscapes, from traditional to industrialized societies. For nearly three decades, she has dedicated her work to studying infectious diseases among the Orang Asli (indigenous) communities of Peninsular Malaysia, collaborating closely with Hospital Orang Asli Gombak. Her contributions to national policy, including the Orang Asli Development Policy (DPOA), reflect her deep commitment to community welfare. Her collaboration with New York University led to a groundbreaking discovery, published in Science (2016), revealing how low levels of helminth (worm) infections promote the growth of probiotic gut microbiota. Her gut microbiome research has since expanded to studies among HIV and cancer patients. More recently, in partnership with the National Institutes of Health (NIH) in the USA, she has deepened investigations into parasitic infections, gut microbiome dynamics, and the relationship between skin infections and the skin microbiome. Her work is supported by numerous national and international grants, including the prestigious US NIH R01 grants. She was recently awarded another NIH R01 grant as the principal investigator. She has published over 250 peer-reviewed scientific articles, contributed to nine book chapters, and authored three books. As a dedicated mentor, she has supervised more than 40 postgraduate students to completion and hosted researchers through extensive collaborations with institutions in the US, UK, Australia, Germany, Japan, the Philippines, Thailand, Indonesia, and Singapore. She has also held visiting research and academic positions at leading institutions, including the Scottish Parasite Diagnostic and Reference Laboratory in Glasgow, Scotland; the Department of Veterinary Science at the University of Melbourne, Australia; the Massachusetts Institute of Technology (MIT), USA; and the Department of Molecular Parasitology and Tropical Diseases at Taipei Medical University, Taiwan. She has earned numerous accolades, including the MSPTM Medal (2008) for outstanding young scientists, the Universiti Malaya Excellent Lecturer Award for Science Disciplines (2015), and the Top Research Scientists of Malaysia Award (2016). In 2017, she was inducted as a Fellow of the Academy of Sciences Malaysia. She has been consistently recognized in Stanford University's list of the top 2% of scientists globally in her field. In 2021, she was awarded the Fulbright Scholar Award (2021/2022) for a fellowship at the Laboratory of Parasitic Diseases at NIAID, NIH, USA. Most recently, she received the prestigious Sandosham Gold Medal Award in 2024, the highest honour from the Malaysian Society of Parasitology and Tropical Medicine, in recognition of her outstanding contributions to parasitology and tropical medicine. Deeply passionate about her work with the Orang Asli communities, she remains committed to inspiring and empowering her colleagues and students to reach their fullest potential.  

Dr. Faissal obtained his medical degree from the University of Wales College of Medicine, Cardiff, United Kingdom, in 2001. He completed his housemanship and subsequently served as a Senior House Officer (SHO) in Wales before returning to Malaysia in 2005. He was appointed as a trainee lecturer under Universiti Teknologi MARA (UiTM) at the Selayang Campus and enrolled in the Master of Orthopaedic Surgery programme at the Universiti Malaya (UM) in 2006. During his training, he served as Chief Resident and successfully completed his clinical master's degree in 2010. Dr. Faissal practiced orthopaedic surgery at Selayang Hospital and UiTM Sungai Buloh Campus, managing a wide spectrum of general orthopaedic cases, complex trauma, joint arthroplasty, and arthroscopy. He pursued subspecialty training in orthopaedic oncology through a two-year fellowship at Universiti Malaya Medical Centre (UMMC) from 2013 to 2015, and later passed the National Board of Orthopaedic Oncology examination under the Malaysian Ministry of Health in 2018. He was appointed Head of the Department of Orthopaedic Surgery at UiTM’s Faculty of Medicine, Sungai Buloh Campus, before joining the Faculty of Medicine, Universiti of Malaya in 2015 as a Senior Lecturer and Consultant Orthopaedic Surgeon. He was promoted to Associate Professor in 2021 and has served as the Head of the Department of Orthopaedic Surgery since then. He currently practices at UMMC and the UM Specialist Centre (UMSC).  Dr. Faissal has extensive clinical experience in managing: General orthopaedic conditions Degenerative joint diseases (shoulder, elbow, wrist, hip, and knee osteoarthritis) Traumatic fractures (upper limb, lower limb, pelvis) Bone and soft tissue lumps or swellings (benign and malignant) Bone and soft tissue tumours in adults and children (primary, recurrent, metastatic) Metastatic bone disease and pathological fractures He is proficient in a wide range of orthopaedic surgical procedures, including: Internal and external fixation of fractures Joint replacement (shoulder, elbow, hip, and knee), including revision surgeries Robotic knee joint replacement surgery Tumour biopsy and excision (bone and soft tissue) Wide resection of musculoskeletal tumours Limb salvage with skeletal reconstruction using endoprostheses, bone grafts, and arthrodesis Soft tissue reconstruction, flaps, and skin grafting Revision of failed reconstructions or infected endoprostheses Prophylactic fixation and surgical treatment of bone metastasis Amputations at all levels of upper and lower limbs Dr. Faissal is actively involved in teaching, research, and postgraduate supervision. He has authored scientific articles in peer-reviewed journals and has presented at national and international conferences, including the Malaysian Orthopaedic Association (MOA), the International Society of Limb Salvage (ISOLS), and the Asia Pacific Musculoskeletal Tumour Society (APMSTS).